Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates

Completed · Not applicable

Conditions studied: Respiratory Distress Syndrome

In brief

The primary objective of this research is to compare the need for intubation and mechanical ventilation in the first seven days of life for infants with respiratory distress syndrome (RDS) on nasal continuous positive airway pressure (nCPAP) who receive surfactant via a Laryngeal Mask Airway (LMA) with those who are maintained on nCPAP and do not receive surfactant.

Key facts

Study ID
NCT01116921
Run by
University of Minnesota
People needed
103
Starts
2011-02-01
Expected to finish
2015-04-01
Last updated by the study team
2017-02-27

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.